These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1474619)

  • 1. Components of the increased circulating proteolytic activity in pediatric burn patients.
    Neely AN; Warden GD; Rieman M; Friedberg DL; Holder IA
    J Trauma; 1992 Dec; 33(6):807-12. PubMed ID: 1474619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients undergoing reconstructive surgery versus unburned children as "controls" in studies of pediatric patients with burns.
    Neely AN; Rieman MT; Warden GD
    J Burn Care Rehabil; 1995; 16(4):418-21. PubMed ID: 8582921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemostasis in burn patients and treatment with heparin. Relation to prognosis and infection. Pattern of blood levels of prekallikrein, alpha-2-macroglobulin, antithrombin III, plasminogen and alpha-2-antiplasmin].
    Hainaut J; Dhennin C; Guilbaud J
    Nouv Rev Fr Hematol (1978); 1982; 24(6):375-81. PubMed ID: 6188103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum elastase and its inhibitors in the blood of heavily burnt patients.
    Miskulin M; Moati F; Robert AM; Robert L; Monteil R; Guilbaud J
    J Clin Pathol; 1978 Sep; 31(9):866-71. PubMed ID: 81839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between circulating proteasome activity, total protein and c-reactive protein levels following burn in children.
    Matuszczak E; Tylicka M; Dębek W; Hermanowicz A; Ostrowska H
    Burns; 2014 Aug; 40(5):842-7. PubMed ID: 24290960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma proteolytic activity following burns.
    Neely AN; Nathan P; Highsmith RF
    J Trauma; 1988 Mar; 28(3):362-7. PubMed ID: 3127596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of elastase in plasma of burned patients in relation to other inflammation parameters.
    Barisoni D; Bellavite P; Sorio A; Bonazzi ML; Zermani R; Bortolani A
    Burns; 1991 Apr; 17(2):141-6. PubMed ID: 2054072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved prognosis of fulminant hepatic failure (FHF) after plasma derivative replacement therapy. Enhanced proteolysis of hemostatic proteins confirmed by proteinase-inhibitor complexes determination.
    Egbring R; Seitz R
    Z Gastroenterol; 1990 Feb; 28(2):104-9. PubMed ID: 2138832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of proteolytic activity on virulence of Candida albicans in burned mice.
    Neely AN; Holder IA
    Infect Immun; 1990 Jun; 58(6):1527-31. PubMed ID: 2187801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elastase and suppressor active peptide activity following burn injury.
    Ozkan AN; Pinney E; Hoyt DB; Ninnemann J; Hansbrough J
    J Trauma; 1988 Feb; 28(2):207-10. PubMed ID: 3346919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic activity and fatal gram-negative sepsis in burned mice: effect of exogenous proteinase inhibition.
    Neely AN; Miller RG; Holder IA
    Infect Immun; 1994 Jun; 62(6):2158-64. PubMed ID: 8188336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An epidemiological investigation of pediatric patients under 14 with large area burns: a multicenter study].
    Cheng WF; Zhao DX; Shen ZA; Zhang HY; Tu JJ; Yuan ZQ; Duan P; Song GD
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(6):462-467. PubMed ID: 28219136
    [No Abstract]   [Full Text] [Related]  

  • 14. Marked increase in plasma interleukin-6 in burn patients.
    Ueyama M; Maruyama I; Osame M; Sawada Y
    J Lab Clin Med; 1992 Nov; 120(5):693-8. PubMed ID: 1385556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elastase and alpha 1-protease inhibitor in burn wound exudates.
    Prager MD; Herring M; Germany B; Baxter CR
    J Burn Care Rehabil; 1991; 12(4):300-5. PubMed ID: 1939300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients.
    Cordova C; Musca A; Violi F; Alessandri C; Ferro D; Piromalli A; Balsano F
    Haemostasis; 1984; 14(2):218-22. PubMed ID: 6564063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in PMN-elastase in blood and in renal and plasma kallikrein-kinin systems after severe burn injury.
    Bönner G; Niermann W; Festge R; Büchsler U
    Adv Exp Med Biol; 1988; 240():499-503. PubMed ID: 2469308
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dynamics of proteolysis and the prekallikrein-kallikrein system of human blood plasma in burn injury].
    Veremeenko KN; Vasil'chuk IuM; Kozinets GP; Pogorelaia NF; Povstianoĭ NE
    Klin Khir (1962); 1984 Mar; (3):22-5. PubMed ID: 6201645
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical investigations after burning injury: complement system, protease-antiprotease balance and acute-phase reactants.
    Faymonville ME; Micheels J; Bodson L; Jacquemin D; Lamy M; Adam J; Duchateau J
    Burns Incl Therm Inj; 1987 Feb; 13(1):26-33. PubMed ID: 2435380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality determinants in massive pediatric burns. An analysis of 103 children with > or = 80% TBSA burns (> or = 70% full-thickness).
    Wolf SE; Rose JK; Desai MH; Mileski JP; Barrow RE; Herndon DN
    Ann Surg; 1997 May; 225(5):554-65; discussion 565-9. PubMed ID: 9193183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.